Resection Device for Cancer Surgery

The device has been cleared by the U.S. Food and Drug Administration (FDA) and has also received the CE Mark.

The HABIB4X resection device was developed by Rita Medical Systems, Inc. (Fremont, CA, USA). The device coagulates a "surgical resection plane” to facilitate a fast dissection with limited blood loss. The company believes this technology will be utilized in liver cancer surgeries since it is designed to minimize blood loss and blood transfusion during surgery. The device is designed to work on the current Rita radiofrequency ablation (RFA) platform of 1500X generators.

The device includes the following features: a bipolar electrode device designed for fast tissue ablation and coagulation, automatic operation with Rita 1500X generator software upgrade, minimized blood loss during surgical tissue resection, and reduced costs interest to the surgery, oncology, and cancer communities, which include existing as well as many potential new customers,” observed associated with resection procedures.

"With our focus on cancer therapies, we expect the HABIB4X to be a strong addition to our product portfolio and for it to be of Joseph DeVivo, president and CEO of Rita Medical Systems.





Related Links:
Rita Medical Systems